Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.15
Delayed Data
As of Apr 24
 +0.14 / +2.00%
Today’s Change
6.71
Today|||52-Week Range
11.93
-12.80%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close7.01
Today’s open6.98
Day’s range6.98 - 7.18
Volume283,490
Average volume (3 months)413,340
Market cap$289.9M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-473.39%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+16.26%
P/E ratio4.4
Price/Sales1.97
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...-0.15-1.03%
GLYCGlycoMimetics Inc-0.94-5.30%
TLGTTeligent Inc+0.05+1.46%
DEPODepomed Inc+0.04+0.59%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$174.2M
Annual profit (last year)$67.8M
Net profit margin38.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Operating Officer &
Executive Vice President
Gregory J. Divis
Corporate headquarters
Dublin, Dublin

Forecasts